Randox Toxicology Ltd.
Pankaj Sinha is a seasoned sales executive with extensive experience in the biotechnology and toxicology sectors. Currently serving as Vice President of Sales at Randox Toxicology Ltd. since January 2012, Pankaj Sinha has progressed through various leadership roles, including Director of Sales for North America and Business Manager for North America. Prior to this, Pankaj Sinha held the position of US National Sales Manager and Southern Regional Manager at Randox from July 2005 to December 2011. Earlier career experience includes serving as Regional Business Manager at GVK Biosciences and various sales management and marketing roles at bioMerieux. Pankaj Sinha holds a Master of Business Administration from the Institute Of Marketing and Management, a Bachelor's degree from Bangalore University, and has completed a program in Strategy Execution from Harvard Business School Online.
This person is not in any teams
This person is not in any offices
Randox Toxicology Ltd.
Delivering innovative solutions for fast and accurate drug detection, Randox Toxicology is a primary manufacturer of Biochip Array Technology, ELISA, reagents, automated systems and quality control material for clinical and forensic toxicology. With the world’s largest toxicology test menu detecting over 500 drugs and metabolites, Randox Toxicology are continually first to market with novel drug tests including synthetics cannabinoids, kratom, DOx Series and bath salts. Patented Biochip Array Technology, designed to work across multiple matrices, boasts cutting-edge multiplex testing capabilities facilitating simultaneous drug detection from a single sample. Significant re-investment in Research & Development has allowed Randox Toxicology to transform the landscape of drugs of abuse testing, offering the most advanced screening technology on the market.